Tech Company Financing Transactions
Traverse Biosciences Funding Round
Traverse Biosciences secured a $100 thousand Seed venture capital round on 6/5/2014. Investors included Accelerate LI.
Transaction Overview
Company Name
Announced On
6/5/2014
Transaction Type
Accelerator
Amount
$100,000
Round
Seed
Investors
Proceeds Purpose
The company will use the proceeds to accelerate its initial development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Health Sciences Dr. 314
Stony Brook, NY 11790
USA
Stony Brook, NY 11790
USA
Phone
Website
Email Address
Overview
Traverse Biosciences is commercializing novel drug candidates for the treatment of inflammatory diseases and related conditions affecting humans and companion animals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Scaduto
Browse more venture capital transactions:
Prev: 6/5/2014: MacuLogix venture capital transaction
Next: 6/5/2014: Ambition venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs